Alginate-based long-acting injectable formulations: recent advances, biomedical applications, and translational challenges

Currently, numerous short-acting formulations are prescribed to patients to administer various therapeutics, which requires repetition of dosage, that may lead to poor patient compliance. Long-acting injectables are such kind of controlled or sustained-release novel formulation that can be fabricated to deliver the active ingredients into the target area for a prolonged time, lasting days, weeks, or months after administration. Alginate-based long-acting injectable (LAI) formulations are comparatively new in the market. Alginate is a natural polymer and a polysaccharide obtained from brown seaweed and some special bacteria. The biocompatibility and biodegradability play an important role in long-acting injectable formulations. As a result, alginate-based LAIs may offer good biocompatibility and provide prolonged drug release, depending on the formulation design and drug release characteristics. Using the latest technology in LAIs can also control the immediate burst release of the active ingredients so that unwanted effects can be reduced. Relevant articles were taken from Google Scholar, Web of Science, and Scopus, covering studies published between 2000 and 2026. This review will focus on various latest technologies for the preparation of alginate-based LAIs and their mechanistic release profiles, and lastly, the applications and challenges toward the biomedical field will also be discussed. Short-acting medications can reduce patient compliance because of their frequent dosing. On the other hand, long-acting injectable formulations can release drugs in a controlled manner, decreasing the need for repeated administration. A natural, biodegradable polymer, alginate, is promising for developing this type of formulation. This study will concentrate on the current technologies used to manufacture long-acting injectable formulations based on alginate and their diverse mechanistic release profiles.

Authors

Publication Details

Journal
Figshare
Published
2026-11-12
DOI
https://doi.org/10.6084/m9.figshare.34992683
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alginate-based long-acting injectable formulations: recent advances, biomedical applications, and translational challenges

Swarupananda Mukherjee, Ayon Dutta, Dipanjan Karati, Subhasis Chakraborty et al.
Figshare
Advanced Drug Delivery Systems
article

Alginate-based long-acting injectable formulations: recent advances, biomedical applications, and translational challenges

Swarupananda Mukherjee, Ayon Dutta, Dipanjan Karati, Subhasis Chakraborty, Koustav Dutta, Bhupendra Prajapati, Dipanjana Ash, Joyeeta Bhattacharya
article en

Abstract

Currently, numerous short-acting formulations are prescribed to patients to administer various therapeutics, which requires repetition of dosage, that may lead to poor patient compliance. Long-acting injectables are such kind of controlled or sustained-release novel formulation that can be fabricated to deliver the active ingredients into the target area for a prolonged time, lasting days, weeks, or months after administration. Alginate-based long-acting injectable (LAI) formulations are comparatively new in the market. Alginate is a natural polymer and a polysaccharide obtained from brown seaweed and some special bacteria. The biocompatibility and biodegradability play an important role in long-acting injectable formulations. As a result, alginate-based LAIs may offer good biocompatibility and provide prolonged drug release, depending on the formulation design and drug release characteristics. Using the latest technology in LAIs can also control the immediate burst release of the active ingredients so that unwanted effects can be reduced. Relevant articles were taken from Google Scholar, Web of Science, and Scopus, covering studies published between 2000 and 2026. This review will focus on various latest technologies for the preparation of alginate-based LAIs and their mechanistic release profiles, and lastly, the applications and challenges toward the biomedical field will also be discussed. Short-acting medications can reduce patient compliance because of their frequent dosing. On the other hand, long-acting injectable formulations can release drugs in a controlled manner, decreasing the need for repeated administration. A natural, biodegradable polymer, alginate, is promising for developing this type of formulation. This study will concentrate on the current technologies used to manufacture long-acting injectable formulations based on alginate and their diverse mechanistic release profiles.

Figshare
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon